A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis

NCT07326813 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

477

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: D-2570 Tablet
DRUG: BMS-986165 Tablet
DRUG: Placebo

Sponsor

InventisBio Co., Ltd